RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
GeneFerm Biotechnology Co Stock

GeneFerm Biotechnology Co Equity 2024

GeneFerm Biotechnology Co Equity

892.84 M TWD

Ticker

1796.TWO

ISIN

TW0001796001

In 2024, GeneFerm Biotechnology Co's equity was 892.84 M TWD, a 7.47% increase from the 830.77 M TWD equity in the previous year.

GeneFerm Biotechnology Co Aktienanalyse

What does GeneFerm Biotechnology Co do?

GeneFerm Biotechnology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing GeneFerm Biotechnology Co's Equity

GeneFerm Biotechnology Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding GeneFerm Biotechnology Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating GeneFerm Biotechnology Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

GeneFerm Biotechnology Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in GeneFerm Biotechnology Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

What is the equity of GeneFerm Biotechnology Co this year?

GeneFerm Biotechnology Co has equity of 892.84 M TWD this year.

What was the equity of GeneFerm Biotechnology Co compared to the previous year?

The equity of GeneFerm Biotechnology Co has increased/decreased by 7.47% increased compared to the previous year.

What impact does a high equity have on investors of GeneFerm Biotechnology Co?

A high equity is advantageous for investors of GeneFerm Biotechnology Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of GeneFerm Biotechnology Co?

A low equity can be a risk for investors of GeneFerm Biotechnology Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of GeneFerm Biotechnology Co affect the company?

An increase in equity of GeneFerm Biotechnology Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of GeneFerm Biotechnology Co affect the company?

A reduction in equity of GeneFerm Biotechnology Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of GeneFerm Biotechnology Co?

Some factors that can affect the equity of GeneFerm Biotechnology Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of GeneFerm Biotechnology Co so important for investors?

The equity of GeneFerm Biotechnology Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can GeneFerm Biotechnology Co take to change the equity?

To change equity, GeneFerm Biotechnology Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does GeneFerm Biotechnology Co pay?

Over the past 12 months, GeneFerm Biotechnology Co paid a dividend of 1.5 TWD . This corresponds to a dividend yield of about 3.15 %. For the coming 12 months, GeneFerm Biotechnology Co is expected to pay a dividend of 1.5 TWD.

What is the dividend yield of GeneFerm Biotechnology Co?

The current dividend yield of GeneFerm Biotechnology Co is 3.15 %.

When does GeneFerm Biotechnology Co pay dividends?

GeneFerm Biotechnology Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of GeneFerm Biotechnology Co?

GeneFerm Biotechnology Co paid dividends every year for the past 2 years.

What is the dividend of GeneFerm Biotechnology Co?

For the upcoming 12 months, dividends amounting to 1.5 TWD are expected. This corresponds to a dividend yield of 3.15 %.

In which sector is GeneFerm Biotechnology Co located?

GeneFerm Biotechnology Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von GeneFerm Biotechnology Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GeneFerm Biotechnology Co from 7/31/2024 amounting to 2 TWD, you needed to have the stock in your portfolio before the ex-date on 7/10/2024.

When did GeneFerm Biotechnology Co pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of GeneFerm Biotechnology Co in the year 2023?

In the year 2023, GeneFerm Biotechnology Co distributed 1 TWD as dividends.

In which currency does GeneFerm Biotechnology Co pay out the dividend?

The dividends of GeneFerm Biotechnology Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von GeneFerm Biotechnology Co

Our stock analysis for GeneFerm Biotechnology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GeneFerm Biotechnology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.